C4 Therapeutics develops drugs that remove disease-causing proteins from cells, with candidates in cancer and inflammation. It last closed at $2.48 on Nov 20, up 1.64% on the day. The next earnings report for CCCC is expected around Thu, Feb 25, 2027. For the quarter ended Sep 2026, CCCC reported EPS of -$0.16 on revenue of $8.5M, with revenue down 24.6% from a year ago. Over its last 8 reports the stock moved an average of 6.6% the session after earnings. Over the last 12 months CCCC insiders bought $0 of stock on the open market and sold $145K, according to SEC Form 4 filings.
AI Auto Pilots
Is CCCC in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CCCC.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CCCCStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CCCC · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 19% below its 20 day and 22% below its 50 day average. It is 32% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 33), near oversold. The nearest support is the Pivot at $2.45, and the nearest resistance the Pivot R1 at $2.58.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 8.9%/day
Key levels
$5.1752 week high+108.5%
$3.44100 day average+38.7%
$3.27200 day average+31.9%
$3.25Swing high (Oct 22)+31.0%
$3.0350 day average+22.2%
$2.9520 day average+19.0%
$2.58Pivot R1+4.0%
$2.48Last close
$2.45Pivot−1.2%
$2.35Pivot S1−5.2%
$1.6952 week low−31.9%
Indicators
RSI (14)
33.43
Weak, oversold below 30
Neutral
MACD
-0.17
Below its signal line
Bearish
Stochastic
9.8
Near the bottom of its range
Oversold
ADX (14)
24.7
Weak trend
Williams %R
-85.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-132.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−20.0%
Change over 10 sessions
Bearish
ATR (14)
$0.22
Typical daily range, 8.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 21.8%/day
Key levels
$5.1752 week high+108.5%
$3.44100 day average+38.7%
$3.27200 day average+31.9%
$3.25Swing high (Oct 22)+31.0%
$3.0350 day average+22.2%
$2.9520 day average+19.0%
$2.58Pivot R1+4.0%
$2.48Last close
$2.45Pivot−1.2%
$2.35Pivot S1−5.2%
$1.6952 week low−31.9%
Indicators
RSI (14)
38.83
Weak, oversold below 30
Neutral
MACD
-0.14
Below its signal line
Bearish
Stochastic
15.3
Near the bottom of its range
Oversold
ADX (14)
21.3
Weak trend
Williams %R
-92.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-156.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−29.3%
Change over 10 sessions
Bearish
ATR (14)
$0.54
Typical daily range, 21.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CCCC
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CCCC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CCCC usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CCCCHow many large options trades hit CCCC, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CCCC in the last 90 days.
From SEC Form 4 filings by CCCC's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CCCC is in one of them and how their past CCCC trades turned out.
C4 Therapeutics is a biopharmaceutical company based in Watertown, Massachusetts. It develops medicines based on targeted protein degradation, a process that removes disease-causing proteins from cells. Its most advanced drug candidates are being tested in cancers, including multiple myeloma and lung cancer, and it is also building programs for inflammation and neurological diseases. The company works with partners such as Merck KGaA, Roche and Pfizer on drug discovery and development.